Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-067037
Filing Date
2025-05-08
Accepted
2025-05-08 16:20:37
Documents
67
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tecx-20250331.htm   iXBRL 10-Q 2286244
2 EX-31.1 tecx-ex31_1.htm EX-31.1 14809
3 EX-31.2 tecx-ex31_2.htm EX-31.2 14930
4 EX-32.1 tecx-ex32_1.htm EX-32.1 10309
  Complete submission text file 0000950170-25-067037.txt   8114775

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tecx-20250331.xsd EX-101.SCH 1215260
70 EXTRACTED XBRL INSTANCE DOCUMENT tecx-20250331_htm.xml XML 1174629
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38537 | Film No.: 25926527
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)